Tag: HIV Prevention

  • HIV and Your Gut Microbiome: Prebiotics & Probiotics

    Our bodies are teeming with trillions of microorganisms – bacteria, viruses, fungi, and more – collectively known as the microbiome. This complex ecosystem is crucial for our health, but when its delicate balance is disrupted, disease can follow. For individuals living with HIV, understanding the gut microbiome’s role is becoming increasingly important.

    HIV’s Impact on the Gut Microbiome

    The HIV virus launches an aggressive attack on the body’s immune system, particularly targeting specialized tissues surrounding the gut. This assault leads to the destruction of vital immune cells, known as CD4+ lymphocytes, a process that can cause irreversible damage. Even with effective HIV therapy, the gut cells lost in the early stages of infection are never fully replaced.

    This damage to the intestinal wall has significant consequences. It allows small amounts of bacteria to leak into the bloodstream, triggering a low-grade inflammatory response. While HIV medications help reduce this inflammation, levels often remain higher than normal, even with treatment. This persistent inflammation can harm blood vessels and increase the risk of cardiovascular disease.

    Changes in Gut Bacteria Composition

    Beyond bacterial leakage, HIV infection also alters the composition of the gut microbiome itself. The beneficial bacteria that normally reside in the gut, essential for digestion, nutrient absorption, and vitamin production, are gradually replaced by less beneficial species. This shift further compromises gut health and overall well-being.

    Can Prebiotics and Probiotics Help?

    The question arises: can we target the gut microbiome to improve health outcomes for those with HIV? Two promising avenues are prebiotics and probiotics.

    • **Prebiotics:** These are foods or supplements, rich in dietary fiber, that nourish and promote the growth of beneficial bacteria in the large intestine through fermentation.
    • **Probiotics:** These are the beneficial bacteria themselves, found in fermented foods like yogurt with live cultures and sauerkraut, or available as tablet supplements. Common examples include Lactobacillus and Bifidobacterium.

    Evidence and Precautions

    Studies have shown that consuming yogurt enriched with probiotics can lead to modest increases in CD4+ lymphocytes in HIV patients undergoing treatment. Other research suggests probiotic supplements may help reduce inflammation, decrease bacterial leakage from the gut, and contribute to a more normalized gut microbiome.

    However, a word of caution is necessary. There have been rare instances where HIV patients, particularly those with advanced disease, not on treatment, and with other contributing health conditions, developed infections from probiotics. For individuals with well-controlled HIV on medication, modest consumption of yogurt or probiotic supplements is likely safe. It’s crucial to discuss these options with your healthcare provider or a nutritionist.

    While some of the damage caused in the gut by HIV may be permanent, taking effective HIV therapy is the most effective way to maintain long-term health. The use of probiotics and a healthy diet (with prebiotics) may provide additional benefits. — Dr. Keith Crawford

    While effective HIV therapy remains the cornerstone of long-term health management, incorporating prebiotics through a healthy diet and considering probiotics, under medical guidance, may offer additional benefits for supporting gut health and potentially improving overall health outcomes.

    Have you explored the use of prebiotics or probiotics for your health? Share your experiences and insights in the comments below!

  • Yeztugo®: A New Twice-Yearly HIV Prevention Option

    A significant advancement in HIV prevention has arrived with the FDA approval of Yeztugo® (lenacapavir), the first and only injectable HIV prevention shot requiring administration just twice a year. This long-acting medication offers powerful protection without the daily commitment of oral PrEP, addressing barriers that have historically limited access, particularly for Black and Brown communities, women, and individuals in the Southern U.S.

    What is Yeztugo® and Who Can Take It?

    Yeztugo® is a long-acting injectable medication designed to significantly reduce the risk of acquiring HIV infection. It is intended for individuals who do not currently have HIV but are seeking protection, whether they are new to PrEP or considering switching from daily oral medications. The medication is suitable for adults and adolescents weighing at least 77 pounds (approximately 35 kg) who are at higher risk for HIV, including those who have engaged in condomless sex, experienced a recent STI, or have a partner living with HIV.

    Why This Approval Matters Now

    Despite the availability of PrEP since 2012, HIV diagnoses remain a concern in the U.S., with over 100 new infections daily in 2023. PrEP usage is notably underutilized among key populations, including women, Black/African American and Latine/Hispanic individuals, and those residing in the U.S. South. Yeztugo®’s twice-yearly format offers a discreet and potentially more manageable option, which could significantly improve adherence and protection rates for these communities. Its potential impact has been recognized globally, with the journal Science naming lenacapavir (the active drug in Yeztugo®) its 2024 “Breakthrough of the Year.”

    Proven Efficacy and Inclusive Research

    Clinical trials have demonstrated remarkable efficacy for Yeztugo®. In two large global studies, PURPOSE 1 and PURPOSE 2, over 99.9% of participants receiving Yeztugo® remained HIV-negative. The PURPOSE program itself is noted as the most inclusive HIV prevention clinical trial program ever conducted, with a specific focus on Black women, LGBTQ+ individuals, and communities in Africa and Latin America, ensuring the research was conducted “for us and with us.”

    How Yeztugo® Works and Potential Side Effects

    Yeztugo® works by blocking HIV at various stages of its life cycle, preventing it from taking hold in the body. The initial administration involves two pills and two injections on Day 1, followed by two more pills on Day 2. Subsequently, individuals receive two injections every six months at a clinic or doctor’s office. Clinical trials indicated that Yeztugo® was generally well-tolerated, with the most common side effects being injection site soreness, headache, and nausea. Importantly, the twice-yearly format eliminates the daily reminder and potential stigma associated with keeping bottles of medication visible, offering a discreet and convenient solution.

    Cost and Accessibility

    Gilead, the manufacturer of Yeztugo®, states that the medication will be priced comparably to other branded PrEP medications. For uninsured individuals, the Gilead Advancing Access program may provide free medication. Copay assistance is also available, encouraging individuals not to assume affordability is a barrier. More information can be found at www.yeztugo.com.

    Is Yeztugo® Right for You?

    Yeztugo® could be a suitable option for individuals who are not living with HIV, desire a simpler and more discreet method of protection, prefer injections over daily pills, or engage in activities that increase HIV risk, particularly when condom use is inconsistent. It is essential to undergo an HIV test before each injection, a process typically managed by a healthcare provider.

    Currently approved in the U.S. and the European Union’s 27 member states, plus Norway, Iceland, and Liechtenstein (under the brand name Yeytuo®), Gilead is working to make Yeztugo® available in more countries, including South Africa, Brazil, and Canada. This expansion signifies a global commitment to providing diverse HIV prevention options.

    If you’re interested in Yeztugo®, talk to your healthcare provider or visit www.yeztugo.com to learn more. What are your thoughts on this new HIV prevention option? Share in the comments below!